(Q43782939)

26 November 2017

title

Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins (English)

1 reference

26 November 2017

Hexham JM

1

1 reference

26 November 2017

Dudas D

2

1 reference

26 November 2017

Hugo R

3

1 reference

26 November 2017

Thompson J

4

1 reference

26 November 2017

King V

5

1 reference

26 November 2017

Dowling C

6

1 reference

26 November 2017

Neville DM Jr

7

1 reference

26 November 2017

Digan ME

8

1 reference

26 November 2017

Lake P

9

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

38

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

397-408

1 reference

Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

The T cell receptor/CD3 complex: a dynamic protein ensemble

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Clinical trials of targeted toxins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Identification of a monoclonal antibody specific for a murine T3 polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Expression of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Differentiation antigens on rhesus monkey lymphocytes. II. Characterization of RhT3, a CD3-like antigen on T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Recombinant toxins: new therapeutic agents for cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Reversal of naturally occuring diabetes in primates by unmodified islet xenografts without chronic immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

Engineering linear F(ab')2 fragments for efficient production in Escherichia coli and enhanced antiproliferative activity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900070-0

7 January 2021

10.1016/S0161-5890(01)00070-0

Identifiers

DOI

1 reference

26 November 2017

1 reference